美股新聞 標題聯播 · 近 24 小時 283 則 · 25 個來源 · 最新 9/20 07:00
本站只列標題、來源、時間與原文連結,不重製內文;著作權屬原媒體與原作者。新聞稿通路(PR Newswire、Business Wire、GlobeNewswire)是公司自己發的,屬第一手;媒體是轉述。
全部 · TPST近 30 天 3 則 · 第 1 / 1 頁
- Tempest Secures Exclusive Option to License Clinical-Stage CD7-Targeted Lentiviral In Vivo CAR-T Platform
- Tempest Therapeutics Announces Up to $7.5 Million Private Placement
- Tempest to Present at the H.C. Wainwright 28th Annual Global Investment Conference
- Tempest Reports Second Quarter 2026 Financial Results and Provides Business Update
- Tempest Announces Development Collaboration with Senlang Biotechnology for TPST-4003, a CD7-Targeted Next-Generation In Vivo CAR-T
- Tempest Unveils Next-Generation In Vivo CAR-T Pipeline, with First Clinical Study Planned for the Fourth Quarter of 2026
- Tempest Therapeutics Appoints Drake Richey and John Yee, MD, MPH to Board of Directors
- Tempest Therapeutics Announces Warrant Exercise for Approximately $2 Million in Gross Proceeds
- Tempest Reports First Quarter 2026 Financial Results and Provides Business Update
- Tempest Presents Clinical Update at ISCT 2026 Annual Meeting
- Tempest to Advance Dual-Targeting CAR-T Platform with Clinical Update at ISCT 2026 Annual Meeting
- Tempest Announces Key Manufacturing Milestone for TPST-2003 Dual-Targeting CD19/BCMA CAR-T
- Tempest Appoints Andrew Fang, Ph.D., as Head of Business Development to Advance Strategic Partnerships and Global Licensing Efforts
- New Strong Buy Stocks for April 10th
- Tempest Reports Year End 2025 Financial Results and Provides Business Update
- Tempest Announces Partnership for TPST-2003 in Preparation for Planned U.S. Registrational Study in 2026
- Tempest Announces Interim Results from Ongoing REDEEM-1 Trial of TPST-2003, Preparing for Potential U.S. Registrational Study in 2026
- Tempest Lays Out Strategic Plan to Advance Recently Acquired Dual-Targeting CAR-T Assets
- Tempest Announces Closing of Strategic Acquisition of Dual-Targeting CAR-T Assets
中文標題是機器翻譯(NLLB 模型,不外送資料),專有名詞靠對照表,語意以英文原題為準。預設藏掉:選股文與自動生成站(Motley Fool、24/7 Wall St、Trefis、MarketBeat…)、加密幣、律師事務所的股東訴訟廣告、非英文、新聞稿裡的人事任命 / 出席活動 / 得獎、個人理財專欄,以及通路稿標題對不到上市公司的。個股標籤是從標題辨識的(通路標準寫法 (NASDAQ: NVDA)、公司名對照);帶「?」的是從摘要辨識、信心較低。來源等級 A / B / C 只影響精選排序,不是對媒體的評價。